×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [7]
Institute of Chi... [4]
THE STATE KEY LA... [3]
INSTITUTE OF COL... [1]
Authors
WANG YITAO [1]
LEE MING YUEN [1]
KWOK HANG FAI [1]
TAM KIN YIP [1]
HE CHENGWEI [1]
GARY WONG [1]
More...
Document Type
Journal article [10]
Review article [1]
Date Issued
2023 [1]
2022 [1]
2021 [2]
2018 [1]
2015 [1]
2014 [2]
More...
Language
英語English [11]
Source Publication
Bioorganic Chemi... [1]
CNS Neuroscience... [1]
Cancers [1]
Chemistry and Bi... [1]
Chinese Journal ... [1]
EUROPEAN JOURNAL... [1]
More...
Indexed By
SCIE [7]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 11
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor
Journal article
Sun, Yaoliang, Chen, Zhiwen, Liu, Guobin, Chen, Xiaoai, Shi, Zihan, Feng, Huixu, Yu, Lei, Li, Guodong, Ding, Ke, Huang, He, Zhang, Zhang, Xu, Shilin. Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor[J]. Bioorganic Chemistry, 2023, 143, 107053.
Authors:
Sun, Yaoliang
;
Chen, Zhiwen
;
Liu, Guobin
;
Chen, Xiaoai
;
Shi, Zihan
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
4.5
/
4.7
|
Submit date:2024/02/22
Cancer
Covalent
Inhibitor
Threonine Tyrosine Kinase (Ttk)
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Journal article
Xie Ying, Feng SenLing, He Fang, Yan PeiYu, Yao XiaoJun, Fan XingXing, Leung Elaine Lai Han, Zhou Hua. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer[J]. PHARMACOLOGICAL RESEARCH, 2022, 186, 106514.
Authors:
Xie Ying
;
Feng SenLing
;
He Fang
;
Yan PeiYu
;
Yao XiaoJun
; et al.
Favorite
|
TC[WOS]:
18
TC[Scopus]:
17
IF:
9.1
/
9.0
|
Submit date:2023/01/30
Drug Resistance
Chemotherapy
Egfr Tyrosine Kinase Inhibitors
Nrf2
Tangeretin
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:
Yuxin Zhao
;
Haiyong Wang
;
Chengwei He
Favorite
|
TC[WOS]:
21
TC[Scopus]:
20
IF:
2.7
/
3.1
|
Submit date:2021/12/08
Non-small Cell Lung Cancer
Targeted Therapy
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor
Drug Resistance
Targeting cd82/kai1 for precision therapeutics in surmounting metastatic potential in breast cancer
Review article
2021
Authors:
Viera, Maximillian
;
Yip, George Wai Cheong
;
Shen, Han Ming
;
Baeg, Gyeong Hun
;
Bay, Boon Huat
Favorite
|
TC[WOS]:
2
TC[Scopus]:
4
IF:
4.5
/
4.9
|
Submit date:2021/11/30
Metastasis Suppressor
Tetraspanins
Tyrosine Kinase Inhibitors
Etoposide
Cd82 Mimics
Epigenetic Drugs
Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Journal article
Yang, Zheng, Zhang, Shao-Lin, Hu, Xiaohui, Tam, Kin Yip. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838, 41-52.
Authors:
Yang, Zheng
;
Zhang, Shao-Lin
;
Hu, Xiaohui
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
27
TC[Scopus]:
27
IF:
4.2
/
4.3
|
Submit date:2018/10/30
Dichloroacetophenone
Epidermal Growth Factor Receptor
Tyrosine Kinase Inhibitor
Synergism
Hypoxia
Oxidative Phosphorylation
Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer
Journal article
Zhang S.-D., McCrudden C.M., Kwok H.F.. Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer[J]. Oncology Letters, 2015, 10(3), 1893-1901.
Authors:
Zhang S.-D.
;
McCrudden C.M.
;
Kwok H.F.
Favorite
|
TC[WOS]:
21
TC[Scopus]:
23
|
Submit date:2018/12/19
Angiogenesis
Fms‑related Tyrosine Kinase 1
Kinase Insert Domain Receptor
Lung Cancer
Survival
Vascular Epidermal Growth Factor a
Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction
Journal article
Wei Cui, Zai-Jun Zhang, Sheng-Quan Hu, Shing-Hung Mak, Da-Ping Xu, Chung-Lit Choi, Yu-Qiang Wang, Wah-Keung Tsim, Ming-Yuen Lee, Jian-Hui Rong, Yi-Fan Han. Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction[J]. CNS Neuroscience and Therapeutics, 2014, 20(3), 244-252.
Authors:
Wei Cui
;
Zai-Jun Zhang
;
Sheng-Quan Hu
;
Shing-Hung Mak
;
Da-Ping Xu
; et al.
Favorite
|
TC[WOS]:
33
TC[Scopus]:
32
|
Submit date:2018/11/06
Cancer
Neuroprotection
Nitric Oxide
Nitric Oxide Synthase
Receptor Tyrosine Kinase
Sunitinib
Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors
Journal article
Lin L.-G., Xie H., Wang Y.-T., Ding J., Ye Y.. Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors[J]. Chemistry and Biodiversity, 2014, 11(5), 776.
Authors:
Lin L.-G.
;
Xie H.
;
Wang Y.-T.
;
Ding J.
;
Ye Y.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
12
|
Submit date:2018/10/31
Epihematoxylol b
Haematoxylon Campechianum
Hematoxylol b, 10-o-methyl-
Homoisoflavonoids
Kinase Insert Domain Receptor (Kdr)
Protein Tyrosine Kinases (Ptks)
Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China
Journal article
Wang Y., Kanegane H., Wang X., Han X., Zhang Q., Zhao S., Yu Y., Wang J., Miyawaki T.. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China[J]. Journal of Clinical Immunology, 2009, 29(3), 352-356.
Authors:
Wang Y.
;
Kanegane H.
;
Wang X.
;
Han X.
;
Zhang Q.
; et al.
Favorite
|
TC[WOS]:
25
TC[Scopus]:
30
|
Submit date:2019/01/16
Bruton's Tyrosine Kinase
Humoral Immunodeficiency
Mutation
X-linked Agammaglobulinemia
Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801
Journal article
Linden A.-M., Storvik M., Lakso M., Haapasalo A., Lee D., Witkin J.M., Sei Y., Castren E., Wong G.. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801[J]. Neuropharmacology, 2001, 40(4), 469-481.
Authors:
Linden A.-M.
;
Storvik M.
;
Lakso M.
;
Haapasalo A.
;
Lee D.
; et al.
Favorite
|
TC[WOS]:
8
TC[Scopus]:
8
|
Submit date:2018/12/18
Cerebral Cortex
Cloning
Dizocilpine
Phencyclidine
Tyrosine Kinase